Alvotech to Manufacture Humira Biosimilar for Quallent Pharmaceuticals

Alvotech (ALVO) and Teva Pharmaceuticals' (TEVA) US affiliate said Tuesday that Alvotech will manufacture a high-concentration interchangeable biosimilar to Humira for Quallent Pharmaceuticals, which

MT NewswiresApr 30 23:32

Alvotech To Manufacture Its High-concentration Interchangeable Biosimilar To Humira For Quallent

RTTNewsApr 30 17:18

AbbVie Stock Slides 6% Amid Concerns About Falling Humira Sales

Seeking AlphaApr 27 02:09

Alvotech's Simponi Biosimilar Candidate Shows Efficacy in Confirmatory Study

Alvotech (ALVO.IC) on Wednesday said the confirmatory clinical trial for its Simponi and Simponi Aria biosimilar candidate AVT05 showed positive results in treating patients with moderate to severe rh

MT NewswiresApr 24 20:07

Alvotech Announced Positive Topline Results From A Confirmatory Clinical Study For AVT05, Alvotech's Proposed Biosimilar To Simponi And Simponi Aria (Golimumab)

Alvotech Announced Positive Topline Results From A Confirmatory Clinical Study For AVT05, Alvotech's Proposed Biosimilar To Simponi And Simponi Aria (Golimumab)

BenzingaApr 24 16:02

Analysts Are Bullish on These Healthcare Stocks: Alvotech (ALVO), Cardinal Health (CAH)

TipRanksApr 23 18:07